Clinical Trial 50268

Washington, DC 20037


This study is evaluating if an additional dose of an Omicron specific COVID-19 booster is safe and how they may affect the immune system. Participants will receive a single vaccination, have 9 in-person visits, and their total participation will last around 12 months. Participants will be compensated for their time and expenses related to their study participation. 

Qualified Participants Must:

• Fully vaccinated and boosted with a FDA-authorized or approved COVID-19 vaccine
• Live in the DC, MD, or VA area
• Are between the ages of 18 to 49
• Are in good general health

Qualified Participants May Receive:

Participants will receive a single dose of an original COVID-19 Omicron specific variant vaccine.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.